AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $4,140,000 | +16.0% | 440,483 | -5.5% | 0.00% | 0.0% |
Q2 2020 | $3,568,000 | +20.0% | 466,277 | -3.1% | 0.00% | 0.0% |
Q1 2020 | $2,973,000 | -49.0% | 481,192 | +0.4% | 0.00% | 0.0% |
Q4 2019 | $5,830,000 | +4.5% | 479,039 | -0.9% | 0.00% | 0.0% |
Q3 2019 | $5,581,000 | +25.2% | 483,215 | +8.2% | 0.00% | 0.0% |
Q2 2019 | $4,459,000 | -19.9% | 446,432 | +3.3% | 0.00% | 0.0% |
Q1 2019 | $5,566,000 | -21.6% | 432,206 | -7.6% | 0.00% | -50.0% |
Q4 2018 | $7,104,000 | -24.6% | 467,714 | -0.7% | 0.00% | 0.0% |
Q3 2018 | $9,417,000 | +4.8% | 470,850 | +2.2% | 0.00% | 0.0% |
Q2 2018 | $8,984,000 | -2.7% | 460,709 | +0.5% | 0.00% | 0.0% |
Q1 2018 | $9,237,000 | +53.6% | 458,445 | +1.0% | 0.00% | 0.0% |
Q4 2017 | $6,014,000 | -29.6% | 453,977 | -2.0% | 0.00% | 0.0% |
Q3 2017 | $8,547,000 | -0.0% | 463,260 | -0.3% | 0.00% | 0.0% |
Q2 2017 | $8,550,000 | -13.4% | 464,647 | +6.1% | 0.00% | -33.3% |
Q1 2017 | $9,875,000 | -34.2% | 437,922 | +1.5% | 0.00% | -40.0% |
Q4 2016 | $15,008,000 | +44.5% | 431,284 | +1.8% | 0.01% | +66.7% |
Q3 2016 | $10,387,000 | +5.4% | 423,796 | +2.9% | 0.00% | 0.0% |
Q2 2016 | $9,852,000 | -1.7% | 411,854 | -3.6% | 0.00% | 0.0% |
Q1 2016 | $10,018,000 | -20.4% | 427,442 | +2.6% | 0.00% | -25.0% |
Q4 2015 | $12,583,000 | -24.4% | 416,805 | -0.5% | 0.00% | -33.3% |
Q3 2015 | $16,635,000 | -30.3% | 418,696 | +21.2% | 0.01% | -14.3% |
Q2 2015 | $23,865,000 | +51.5% | 345,562 | +19.9% | 0.01% | +40.0% |
Q1 2015 | $15,756,000 | +44.8% | 288,265 | +12.9% | 0.01% | +66.7% |
Q4 2014 | $10,883,000 | +32.1% | 255,352 | -1.1% | 0.00% | 0.0% |
Q3 2014 | $8,241,000 | +48.0% | 258,256 | -3.9% | 0.00% | +50.0% |
Q2 2014 | $5,569,000 | -2.9% | 268,792 | -9.3% | 0.00% | 0.0% |
Q1 2014 | $5,734,000 | -27.2% | 296,322 | -8.7% | 0.00% | -33.3% |
Q4 2013 | $7,879,000 | +15.0% | 324,496 | +1.7% | 0.00% | +50.0% |
Q3 2013 | $6,854,000 | -4.4% | 319,158 | -0.9% | 0.00% | -33.3% |
Q2 2013 | $7,166,000 | – | 322,073 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |